190 related articles for article (PubMed ID: 36484954)
1. Fear stress promotes glioma progression through inhibition of ferroptosis by enhancing FSP1 stability.
Bu C; Hu S; Yu J; Li N; Gu J; Sheng Z; Yan Z; Bu X
Clin Transl Oncol; 2023 May; 25(5):1378-1388. PubMed ID: 36484954
[TBL] [Abstract][Full Text] [Related]
2. Targeting Ferroptosis as a Novel Approach to Alleviate Aortic Dissection.
Li N; Yi X; He Y; Huo B; Chen Y; Zhang Z; Wang Q; Li Y; Zhong X; Li R; Zhu XH; Fang Z; Wei X; Jiang DS
Int J Biol Sci; 2022; 18(10):4118-4134. PubMed ID: 35844806
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
4. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
[TBL] [Abstract][Full Text] [Related]
5. METTL3 silenced inhibited the ferroptosis development via regulating the TFRC levels in the Intracerebral hemorrhage progression.
Zhang L; Wang X; Che W; Zhou S; Feng Y
Brain Res; 2023 Jul; 1811():148373. PubMed ID: 37105375
[TBL] [Abstract][Full Text] [Related]
6. Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer.
Cheu JW; Lee D; Li Q; Goh CC; Bao MH; Yuen VW; Zhang MS; Yang C; Chan CY; Tse AP; Sit GF; Liu CX; Ng IO; Wong CM; Wong CC
Cell Mol Gastroenterol Hepatol; 2023; 16(1):133-159. PubMed ID: 36893885
[TBL] [Abstract][Full Text] [Related]
7. YTHDC1 as a tumor progression suppressor through modulating FSP1-dependent ferroptosis suppression in lung cancer.
Yuan S; Xi S; Weng H; Guo MM; Zhang JH; Yu ZP; Zhang H; Yu Z; Xing Z; Liu MY; Ming DJ; Sah RK; Zhou Y; Li G; Zeng T; Hong X; Li Y; Zeng XT; Hu H
Cell Death Differ; 2023 Dec; 30(12):2477-2490. PubMed ID: 37903990
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine-modified HOTAIRM1 promotes vasculogenic mimicry formation in glioma.
Wu Z; Lin Y; Wei N
Cancer Sci; 2023 Jan; 114(1):129-141. PubMed ID: 36086906
[TBL] [Abstract][Full Text] [Related]
9. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
Song Z; Jia G; Ma P; Cang S
Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation-regulated LINC02587 inhibits ferroptosis and promotes the progression of glioma cells through the CoQ-FSP1 pathway.
Wang Z; Cui Y; Wang F; Xu L; Yan Y; Tong X; Yan H
BMC Cancer; 2023 Oct; 23(1):989. PubMed ID: 37848823
[TBL] [Abstract][Full Text] [Related]
11. METTL3 promotes the progression of nasopharyngeal carcinoma through mediating M6A modification of EZH2.
Meng QZ; Cong CH; Li XJ; Zhu F; Zhao X; Chen FW
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4328-4336. PubMed ID: 32373970
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules.
Xavier da Silva TN; Schulte C; Alves AN; Maric HM; Friedmann Angeli JP
Cell Death Dis; 2023 Apr; 14(4):281. PubMed ID: 37080964
[TBL] [Abstract][Full Text] [Related]
13. METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma.
Chang YZ; Chai RC; Pang B; Chang X; An SY; Zhang KN; Jiang T; Wang YZ
Cancer Lett; 2021 Jul; 511():36-46. PubMed ID: 33933553
[TBL] [Abstract][Full Text] [Related]
14. METTL3 facilitates tumor progression via an m
Li T; Hu PS; Zuo Z; Lin JF; Li X; Wu QN; Chen ZH; Zeng ZL; Wang F; Zheng J; Chen D; Li B; Kang TB; Xie D; Lin D; Ju HQ; Xu RH
Mol Cancer; 2019 Jun; 18(1):112. PubMed ID: 31230592
[TBL] [Abstract][Full Text] [Related]
15. Essential role of METTL3-mediated m
Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
[TBL] [Abstract][Full Text] [Related]
16. METTL3-mediated m
Chen X; Gong W; Shao X; Shi T; Zhang L; Dong J; Shi Y; Shen S; Qin J; Jiang Q; Guo B
Ann Rheum Dis; 2022 Jan; 81(1):87-99. PubMed ID: 34706873
[TBL] [Abstract][Full Text] [Related]
17. CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA.
Chen S; Zhang Z; Zhang B; Huang Q; Liu Y; Qiu Y; Long X; Wu M; Zhang Z
Int J Biol Sci; 2022; 18(2):841-857. PubMed ID: 35002529
[TBL] [Abstract][Full Text] [Related]
18. miR-672-3p Promotes Functional Recovery in Rats with Contusive Spinal Cord Injury by Inhibiting Ferroptosis Suppressor Protein 1.
Wang F; Li J; Zhao Y; Guo D; Liu D; Chang S; Qiao H; Li J; Yang Y; Zhang C; Wang R; Li F; Wang D; Li H; He X
Oxid Med Cell Longev; 2022; 2022():6041612. PubMed ID: 35237382
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of HNRNPM inhibits the progression of glioma through inducing ferroptosis.
Wang J; Luo X; Liu D
Cell Cycle; 2023 Oct; 22(20):2264-2279. PubMed ID: 38016815
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of SLC39A14 inhibits glioma progression by promoting erastin-induced ferroptosis SLC39A14 knockdown inhibits glioma progression.
Zhang Y; Wu X; Zhu J; Lu R; Ouyang Y
BMC Cancer; 2023 Nov; 23(1):1120. PubMed ID: 37978473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
